olanzapine/samidorphan decreases effects of fentanyl transdermal by pharmacodynamic antagonism. Contraindicated. Samidorphan elicits opioid antagonistic outcomes and improves risk of precipitating acute opioid withdrawal in patients dependent on opioids.Pediatric Acceptable scientific studies executed thus far have not demonstrated pediatric-unique